Results 221 to 230 of about 108,162 (269)
Some of the next articles are maybe not open access.
Science and Engineering Ethics, 2012
Reductionist explanations in biology generally assume that biological mechanisms are highly deterministic and basically similar between individuals. A contrasting view has emerged recently that takes into account the degeneracy of biological processes--the ability to arrive at a given endpoint by a variety of available paths, even within the same ...
openaire +3 more sources
Reductionist explanations in biology generally assume that biological mechanisms are highly deterministic and basically similar between individuals. A contrasting view has emerged recently that takes into account the degeneracy of biological processes--the ability to arrive at a given endpoint by a variety of available paths, even within the same ...
openaire +3 more sources
From Biological Data to Biological Knowledge
2007Large scale biological knowledge still organization remains a challenge in life sciences. Not only because related information is spread across several distributed information resources, but also because context dependent information retrieval suffers from an absence of semantic capabilities in biological databases.
Volker Stümpflen +2 more
openaire +1 more source
Postmarketing safety of biologics and biological devices
The Spine Journal, 2014Regardless of study design, the approval process of biologics and biological devices cannot identify every possible safety concern. Postmarketing safety surveillance can provide information based on real-world use of medical products in heterogeneous populations and is critical for identifying potentially serious adverse events, events that are too ...
openaire +2 more sources
Models of biological systems and biological processes
Pure and Applied Chemistry, 1994Abstract
openaire +2 more sources
The Importance of Biological Databases in Biological Discovery
Current Protocols in Bioinformatics, 2003AbstractBiological databases play a central role in bioinformatics. They offer scientists the opportunity to access a wide variety of biologically relevant data, including the genomic sequences of an increasingly broad range of organisms. This unit provides a brief overview of major sequence databases and portals, such as GenBank, the UCSC Genome ...
openaire +4 more sources
2012
Drug development is a complex process, requiring scientific and regulatory input at almost all stages from multiple groups of expertise. Small molecule development issues are covered in other parts of this volume. This chapter is devoted to discussing the large molecules, or biologics, and the particular nuances involved in developing these molecules ...
Kevin, Brady, Rob, Webster
openaire +2 more sources
Drug development is a complex process, requiring scientific and regulatory input at almost all stages from multiple groups of expertise. Small molecule development issues are covered in other parts of this volume. This chapter is devoted to discussing the large molecules, or biologics, and the particular nuances involved in developing these molecules ...
Kevin, Brady, Rob, Webster
openaire +2 more sources
Nature Reviews Genetics, 2004
Robustness is a ubiquitously observed property of biological systems. It is considered to be a fundamental feature of complex evolvable systems. It is attained by several underlying principles that are universal to both biological organisms and sophisticated engineering systems.
openaire +2 more sources
Robustness is a ubiquitously observed property of biological systems. It is considered to be a fundamental feature of complex evolvable systems. It is attained by several underlying principles that are universal to both biological organisms and sophisticated engineering systems.
openaire +2 more sources
Dermatologic Clinics
Biologic therapies targeting tumor necrosis factor alpha (TNF-α) (infliximab, adalimumab, certolizumab, etanercept), the p40 subunit shared by IL-12 and IL-23 (ustekinumab), the p19 subunit of IL-23 (guselkumab, tildrakizumab, risankizumab), IL-17A (secukinumab, ixekizumab), IL-17-RA (brodalumab) and both IL-17A and IL-17F (bimekizumab) have ...
Anthony Mitchel, Wride +4 more
openaire +2 more sources
Biologic therapies targeting tumor necrosis factor alpha (TNF-α) (infliximab, adalimumab, certolizumab, etanercept), the p40 subunit shared by IL-12 and IL-23 (ustekinumab), the p19 subunit of IL-23 (guselkumab, tildrakizumab, risankizumab), IL-17A (secukinumab, ixekizumab), IL-17-RA (brodalumab) and both IL-17A and IL-17F (bimekizumab) have ...
Anthony Mitchel, Wride +4 more
openaire +2 more sources
From the updated landscape of the emerging biologics for IBDs treatment to the new delivery systems
Journal of Controlled Release, 2023Xu Helin, Dingwei Li
exaly